Suppr超能文献

免疫抑制患者中利什曼病的新见解。

New insights into leishmaniasis in the immunosuppressed.

机构信息

Swedish International Development Agency (Sida), and Microbiology, Tumor and Cell biology (MTC), Karolinska Institutet, Solna, Sweden.

Federal University of Piauí, Teresina-PI, Brazil.

出版信息

PLoS Negl Trop Dis. 2018 May 10;12(5):e0006375. doi: 10.1371/journal.pntd.0006375. eCollection 2018 May.

Abstract

Immunosuppression contributes significantly to the caseload of visceral leishmaniasis (VL). HIV coinfection, solid organ transplantation, malnutrition, and helminth infections are the most important immunosuppression-related factors. This review briefly describes the challenges of these associations. East Africa and the Indian subcontinent are the places where HIV imposes the highest burden in VL. In the highlands of Northern Ethiopia, migrant rural workers are at a greater risk of coinfection and malnutrition, while in India, HIV reduces the sustainability of a successful elimination programme. As shown from a longitudinal cohort in Madrid, VL is an additional threat to solid organ transplantation. The association with malnutrition is more complex since it can be both a cause and a consequence of VL. Different regimes for therapy and secondary prevention are discussed as well as the role of nutrients on the prophylaxis of VL in poverty-stricken endemic areas.

摘要

免疫抑制是内脏利什曼病(VL)发病的重要原因。HIV 合并感染、实体器官移植、营养不良和寄生虫感染是最重要的与免疫抑制相关的因素。本文简要描述了这些关联所带来的挑战。东非和印度次大陆是 HIV 给 VL 带来最大负担的地方。在埃塞俄比亚北部高地,移民农村工人面临更高的合并感染和营养不良风险,而在印度,HIV 降低了成功消除计划的可持续性。正如马德里的一项纵向队列研究所示,VL 对实体器官移植构成了额外的威胁。与营养不良的关系更为复杂,因为它既可以是 VL 的原因,也可以是 VL 的结果。本文还讨论了不同的治疗和二级预防方案,以及在贫困流行地区营养素在 VL 预防中的作用。

相似文献

1
New insights into leishmaniasis in the immunosuppressed.
PLoS Negl Trop Dis. 2018 May 10;12(5):e0006375. doi: 10.1371/journal.pntd.0006375. eCollection 2018 May.
3
Host resistance to visceral leishmaniasis: prevalence and prevention.
Expert Rev Anti Infect Ther. 2016;14(4):435-42. doi: 10.1586/14787210.2016.1160779.
5
Development of Leishmania vaccines in the era of visceral leishmaniasis elimination.
Trans R Soc Trop Med Hyg. 2015 Jul;109(7):423-4. doi: 10.1093/trstmh/trv039. Epub 2015 Jun 4.
7
Visceral leishmaniasis: a threat to immunocompromised patients in non-endemic areas?
Clin Microbiol Infect. 2007 Aug;13(8):751-3. doi: 10.1111/j.1469-0691.2007.01755.x.
8
Visceral leishmaniasis elimination targets in India, strategies for preventing resurgence.
Expert Rev Anti Infect Ther. 2018 Nov;16(11):805-812. doi: 10.1080/14787210.2018.1532790. Epub 2018 Oct 10.
10
Serial use of pentamidine and miltefosine for treating Leishmania infantum-HIV coinfection.
Parasitol Int. 2016 Oct;65(5 Pt A):444-6. doi: 10.1016/j.parint.2016.06.009. Epub 2016 Jun 22.

引用本文的文献

3
Evaluation of Beauvericin's activity and mode of action against all life stages of for cutaneous Leishmaniasis therapy.
Front Cell Infect Microbiol. 2025 Jun 10;15:1599766. doi: 10.3389/fcimb.2025.1599766. eCollection 2025.
4
Co-endemicity of schistosomiasis and tegumentary leishmaniasis: Spatial co-clustering in endemic areas.
Trop Med Int Health. 2025 Jun;30(6):556-568. doi: 10.1111/tmi.14118. Epub 2025 Apr 27.
6
Feline leishmaniosis in the Mediterranean Basin: a multicenter study.
Parasit Vectors. 2024 Aug 19;17(1):346. doi: 10.1186/s13071-024-06419-x.
7
Serological Screening and Risk Factors Associated with Positivity in Newly Diagnosed HIV Patients in Greece.
Microorganisms. 2024 Jul 10;12(7):1397. doi: 10.3390/microorganisms12071397.
9
Practical Synthesis of 6-Amino-1-hydroxy-2,1-benzoxaborolane: A Key Intermediate of DNDI-6148.
Org Process Res Dev. 2024 Mar 29;28(4):1213-1223. doi: 10.1021/acs.oprd.4c00031. eCollection 2024 Apr 19.

本文引用的文献

1
Nutritional supplements for patients being treated for active visceral leishmaniasis.
Cochrane Database Syst Rev. 2018 Mar 26;3(3):CD012261. doi: 10.1002/14651858.CD012261.pub2.
5
Causes and consequences of higher Leishmania infantum burden in patients with kala-azar: a study of 625 patients.
Trop Med Int Health. 2017 Jun;22(6):679-687. doi: 10.1111/tmi.12877. Epub 2017 May 2.
6
Leishmaniasis and various immunotherapeutic approaches.
Parasitology. 2018 Apr;145(4):497-507. doi: 10.1017/S003118201600216X. Epub 2016 Dec 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验